Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Bliss · SciRah

Researcher profile · Semantic Scholar

J. Bliss

Share profile

J. Bliss — researcher profile on SciRah

h-index: 73
Works: 368
Citations: 31K

Most-cited papers

Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.
I. Garcia-Murillas, N. Chopra, I. Comino-Méndez, M. Beaney +18 more
2019JAMA Oncology377 citations Open access
Semantic Scholar
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials
R. Gray, Rosie Bradley, J. Braybrooke, Zu-Lian Liu +162 more
2019The Lancet328 citations Open access
Semantic Scholar
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial
N. Turner, B. Kingston, L. Kilburn, S. Kernaghan +24 more
2020The Lancet Oncology293 citations Open access
Semantic Scholar
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
Rosie Bradley, J. Braybrooke, R. Gray, R. Hills +96 more
2021The Lancet Oncology259 citations Open access
Semantic Scholar
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer
A. Brunt, J. Haviland, M. Sydenham, R. Agrawal +22 more
2020Journal of Clinical Oncology239 citations Open access
Semantic Scholar
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
N. Chopra, H. Tovey, A. Pearson, R. Cutts +18 more
2020Nature Communications218 citations Open access
Semantic Scholar
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
P. Goodwin, Bing-Shu E. Chen, K. Gelmon, T. Whelan +20 more
2022Journal of the American Medical Association (JAMA)215 citations Open access
Semantic Scholar
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
Rosie Bradley, J. Braybrooke, R. Gray, R. Hills +86 more
2022The Lancet Oncology210 citations Open access
Semantic Scholar
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)
M. Gnant, A. Dueck, S. Frantal, Miguel Martín +36 more
2021Journal of Clinical Oncology206 citations Open access
Semantic Scholar
Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial
I. Smith, J. Robertson, L. Kilburn, M. Wilcox +15 more
2020The Lancet Oncology205 citations Open access
Semantic Scholar
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.
S. Johnston, S. Puhalla, D. Wheatley, A. Ring +33 more
2019Journal of Clinical Oncology193 citations Open access
Semantic Scholar
Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0
S. Tolaney, E. Garrett-Mayer, J. White, V. Blinder +19 more
2021Journal of Clinical Oncology161 citations Open access
Semantic Scholar
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative
P. Aftimos, M. Oliveira, A. Irrthum, D. Fumagalli +51 more
2021Cancer Discovery137 citations Open access
Semantic Scholar
ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor–Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials
N. Turner, C. Swift, L. Kilburn, C. Fribbens +11 more
2020Clinical Cancer Research131 citations
Semantic Scholar
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial.
C. Coles, J. Haviland, A. Kirby, C. Griffin +17 more
2023The Lancet93 citations Open access
Semantic Scholar
Genomic profile of advanced breast cancer in circulating tumour DNA
B. Kingston, R. Cutts, H. Bye, M. Beaney +20 more
2021Nature Communications92 citations Open access
Semantic Scholar
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial
I. Judson, J. Morden, L. Kilburn, M. Leahy +18 more
2019The Lancet Oncology87 citations Open access
Semantic Scholar
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)
Susana Banerjee, J. Stewart, N. Porta, C. Toms +9 more
2021International Journal of Gynecological Cancer54 citations Open access
Semantic Scholar
Implementation of platform trials in the COVID-19 pandemic: A rapid review
A. Vanderbeek, J. Bliss, Z. Yin, C. Yap
2021Contemporary Clinical Trials49 citations Open access
Semantic Scholar
Five-fraction Radiotherapy for Breast Cancer: FAST-Forward to Implementation.
A. Brunt, J. Haviland, A. Kirby, N. Somaiah +3 more
2021Clinics in oncology49 citations Open access
Semantic Scholar
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.
R. Coombes, H. Tovey, L. Kilburn, J. Mansi +21 more
2021JAMA Oncology48 citations Open access
Semantic Scholar
Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid Tumors.
M. Piccart, F. Hilbers, J. Bliss, C. Caballero +10 more
2020Journal of Clinical Oncology46 citations
Semantic Scholar
Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials
R. Gray, Rosie Bradley, Jeremy P. Braybrooke, C. Davies +11 more
201832 citations
Semantic Scholar
Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer
T. Bachelot, P. Cottu, S. Chabaud, F. Dalenc +23 more
2022Journal of Clinical Oncology27 citations Open access
Semantic Scholar
Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial
I. Bhattacharya, J. Haviland, P. Hopwood, C. Coles +3 more
2019Radiotherapy and Oncology25 citations Open access
Semantic Scholar
Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers
E. Schuster, E. López-Knowles, Anastasia Alataki, L. Zabaglo +11 more
2023Nature Communications24 citations Open access
Semantic Scholar
Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant.
L. Malorni, S. Tyekucheva, F. Hilbers, M. Ignatiadis +29 more
2022European Journal of Cancer24 citations Open access
Semantic Scholar
Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies
J. Robertson, A. Di Leo, S. Johnston, S. Chia +5 more
2021npj Breast Cancer24 citations Open access
Semantic Scholar
Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trial
O. Sipos, H. Tovey, J. Quist, S. Haider +14 more
2020Annals of Oncology23 citations Open access
Semantic Scholar
Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis
D. Glynn, J. Bliss, A. Brunt, C. Coles +7 more
2022Breast Cancer Research and Treatment22 citations Open access
Semantic Scholar
Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients
Qiong Gao, E. López-Knowles, M. Cheang, J. Morden +14 more
2019Breast Cancer Research21 citations Open access
Semantic Scholar
Impact of BMI in Patients With Early Hormone Receptor–Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial
G. Pfeiler, D. Hlauschek, E. Mayer, C. Deutschmann +47 more
2023Journal of Clinical Oncology19 citations
Semantic Scholar
Proton Beam Therapy in Breast Cancer Patients: The UK PARABLE Trial is Recruiting.
A. Kirby, J. Haviland, M. Mackenzie, H. Fleming +6 more
2023Clinics in oncology18 citations Open access
Semantic Scholar
Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015)
J. Bliss, H. Tovey, Abigail Evans, C. Holcombe +14 more
2023Breast Cancer Research17 citations Open access
Semantic Scholar
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer
M. Bergamino, E. López-Knowles, G. Morani, H. Tovey +12 more
2022EBioMedicine17 citations Open access
Semantic Scholar
Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in Patients With ER+/HER2− Breast Cancer
M. Dowsett, L. Kilburn, M. Rimawi, C. Osborne +14 more
2021Clinical Cancer Research13 citations Open access
Semantic Scholar
Efficacy of everolimus in patients with HR+/HER2- high risk early stage breast cancer
T. Bachelot, F. Dalenc, S. Chabaud, P. Cottu +16 more
2021Annals of Oncology13 citations Open access
Semantic Scholar
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
E. Agostinetto, L. Ameye, S. Martel, P. Aftimos +16 more
2022npj Breast Cancer12 citations Open access
Semantic Scholar
OC-0291 IMPORT HIGH trial: Dose escalated simultaneous integrated boost radiotherapy in early breast cancer
C. Coles, J. Haviland, A. Kirby, I. Bhattacharya +17 more
2021Radiotherapy and Oncology11 citations Open access
Semantic Scholar
Abstract GS3-06: Results from the plasmaMATCH trial: A multiple parallel cohort, multi-centre clinical trial of circulating tumour DNA testing to direct targeted therapies in patients with advanced breast cancer (CRUK/15/010)
N. Turner, B. Kingston, L. Kilburn, S. Kernaghan +21 more
2020General Session Abstracts11 citations
Semantic Scholar
Is breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trial
I. Bhattacharya, J. Haviland, C. Perotti, D. Eaton +6 more
2019Radiotherapy and Oncology11 citations Open access
Semantic Scholar
Abstract GS3-03: A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT – Randomised EuropeAn celecoxib trial)
R. Coombes, H. Tovey, L. Kilburn, J. Mansi +20 more
201811 citations
Semantic Scholar
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
N. Bundred, N. Porta, A. Brunt, A. Cramer +19 more
2022Clinical Cancer Research10 citations Open access
Semantic Scholar
Randomised single centre double-blind placebo controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline in patients suffering long-term gastrointestinal adverse effects of radiotherapy for pelvic cancer: the PPALM study.
H. Andreyev, J. Matthews, Carolyn Adams, L. Gothard +11 more
2022Radiotherapy and Oncology10 citations Open access
Semantic Scholar
Impact of duration of neoadjuvant aromatase inhibitors on molecular expression profiles in estrogen receptor positive breast cancers
M. Bergamino, G. Morani, J. Parker, Eugene F Schuster +8 more
2021Clinical Cancer Research9 citations Open access
Semantic Scholar
Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study
E. López-Knowles, S. Detre, M. Hills, Eugene F Schuster +10 more
2022Breast Cancer Research7 citations Open access
Semantic Scholar
Abstract GS3-06: Primary results of the cTRAK TN trial: A clinical trial utilising ctDNA mutation tracking to detect minimal residual disease and trigger intervention in patients with moderate and high risk early stage triple negative breast cancer
N. Turner, C. Swift, B. Jenkins, L. Kilburn +21 more
2022Cancer Research7 citations
Semantic Scholar
Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer.
P. Nuciforo, J. Townend, M. Piccart, S. Fielding +23 more
2022European Journal of Cancer7 citations Open access
Semantic Scholar
Accelerated partial breast irradiation: more questions than answers?
C. Coles, J. Bliss, P. Poortmans
2019The Lancet7 citations
Semantic Scholar
Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK – A16037)
Susana Banerjee, H. Tovey, R. Bowen, E. Folkerd +13 more
2020Therapeutic Advances in Medical Oncology6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Dowsett×16
Invite
M. Dowsett — researcher profile on SciRah
L. Kilburn×15
Invite
L. Kilburn — researcher profile on SciRah
D. Cameron×13
Invite
D. Cameron — researcher profile on SciRah
H. Tovey×12
Invite
H. Tovey — researcher profile on SciRah

×8

Invite

A. Skene — researcher profile on SciRah

Invite

M. Piccart — researcher profile on SciRah

Invite

J. Yarnold — researcher profile on SciRah

Invite

J. Haviland — researcher profile on SciRah

Invite

A. Evans — researcher profile on SciRah

Invite

N. Turner — researcher profile on SciRah

Invite

J. Morden — researcher profile on SciRah

J. Robertson×7

Invite

J. Robertson — researcher profile on SciRah